Leucorre:Diseases of the genitourinary system. Leucorre:Diseases of the genitourinary system
Conditions
Interventions
Intervention 1: Control group: Positive Control (G1) received oral Metro gel (metronidazole, 5 grams/day for 5 days). Intervention 2: Control group: Negative Control (G2) received no allopathic medici
Sponsors
Muhammad Institute of Medical and Allied Sciences Multan
Eligibility
Sex/Gender
Female
Age
16 Years to 55 Years
Inclusion criteria
Inclusion criteria: Aged 16-55 year Symptoms of abnormal vaginal discharge Excessive vaginal irritation Vaginal itching Females
Exclusion criteria
Exclusion criteria: Pregnant women (due to altered vaginal flora and fetal safety concerns) Those with prolapsed uterus (potential impact on symptoms), History of malignancy (to avoid treatment-related complications) Severe illnesses (to maintain study integrity) Individuals with known allergies (to prevent confounding reactions).
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Excessive vaginal discharge. Timepoint: 1 month. Method of measurement: The whiff test detected bacterial vaginosis through the presence of a fishy odor, and Gram staining identified bacterial species present in vaginal discharge.;Vaginal discharge examination. Timepoint: 1 month. Method of measurement: The pH test measured vaginal acidity (normal range 3.8-4.5), the whiff test detected bacterial vaginosis through the presence of a fishy odor, and Gram staining identified bacterial species present in vaginal discharge. | — |
Secondary
| Measure | Time frame |
|---|---|
| Back pain. Timepoint: 1 month. Method of measurement: Visual Analog Scale.;Constipation, loss of appetite, painful intercourse and general well-being. Timepoint: 1 month. Method of measurement: By asking questions and discussing with patients. | — |
Countries
Pakistan
Contacts
Public ContactMashhud-Ul-Hasan Abid
Muhammad Institute of Medical and Allied Sciences, Multan
Outcome results
None listed